IP Library Granted Patent US 8,580,522
Granted Patent B2
US 8,580,522 · App. 13/208,963 · Granted Nov 12, 2013

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

Inventor: Joan M. Fallon (Bronxville, NY)
Assignee: Curemark, LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,580,522
App. No.
13/208,963
Granted
Nov 12, 2013
Kind
B2
Abstract

Methods for aiding in the diagnosis of disorders including, but not limited to, PDDs (Pervasive Development Disorders), Dysautonomic disorders, Parkinson's disease and SIDS (Sudden Infant Death Syndrome). In one aspect, a diagnosis method comprises analyzing a stool sample of an individual for the presence of a biological marker (or marker compound) comprising one or more pathogens, which provides an indication of whether the individual has, or can develop, a disorder including, but not limited to, a PDD, Dysautonomia, Parkinsons disease and SIDS. Preferably, the presence of one or more pathogens is determined using a stool immunoassay to determine the presence of antigens in a stool sample, wherein such antigens are associated with one or more pathogens including, but not limited to, Giardia, Cryptosporidium, E. histolytica, C. difficile , Adenovirus, Rotavirus or H. pylori.

Claims (20)

1. A method for determining if an individual has, or can develop, Parkinson's disease, comprising:

obtaining a stool sample from the individual;

analyzing the stool sample with a stool immunoassay for the presence or absence an antigen associated with a pathogen, wherein the pathogen comprises Helicobacter pylori, Cryptosporidium, Entamoeba histolytica, Giardia , or Rotavirus;

detecting the level of chymotrypsin present in the stool sample; and

determining that the individual has, or can develop, Parkinson's Disease based on the presence of the antigen and an abnormally low level of chymotrypsin in the stool sample.

2. The method of claim 1 , wherein the pathogen is Helicobacter pylori.

3. The method of claim 1 , wherein the pathogen is Cryptosporidium.

4. The method of claim 1 , wherein the pathogen is Giardia.

5. The method of claim 1 , wherein the pathogen is Rotavirus.

6. The method of claim 1 , wherein the pathogen is Entamoeba histolytica.

7. A method for determining if an individual has, or can develop, a Dysautonomic disorder, comprising:

obtaining a stool sample from the individual;

analyzing the stool sample with a stool immunoassay for the presence or absence of an antigen associated with a pathogen, wherein the pathogen comprises Helicobacter pylori, Cryptosporidium, Entamoeba histolytica, Giardia , or Rotavirus;

detecting the level of chymotrypsin present in the stool sample; and

determining that the individual has, or can develop, a Dysautonomic disorder based on the presence of the antigen and an abnormally low level of chymotrypsin in the stool sample.

8. The method of claim 7 , wherein the pathogen is Helicobacter pylori.

9. The method of claim 7 , wherein the pathogen is Cryptosporidium.

10. The method of claim 7 , wherein the pathogen is Giardia.

11. The method of claim 7 , wherein the pathogen is Rotavirus.

12. The method of claim 7 , wherein the pathogen is Entamoeba histolytica.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2013
From: FALLON, JOAN M.
To: CUREMARK, LLC
Reel/Frame 031137/0506 →
Continuity (3)
Division 09990909 · Nov 16, 2001
Provisional Application 60249239 · Nov 16, 2000
Related Publication 20120003628A1 · Jan 5, 2012